Abbott Laboratories (NYSE:ABT) Stock Position Decreased by Founders Capital Management
Founders Capital Management cut its stake in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 30.3% in the 3rd quarter, HoldingsChannel.com reports. The fund owned 748 shares of the healthcare product maker’s stock after selling 325 shares during the quarter. Founders Capital Management’s holdings in Abbott Laboratories were worth $72,000 at the end of […]